If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Science Liaison
Download FREE Excerpt
9 Info Graphics
22 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Around the globe, field-based medical teams play a significant role in effectively engaging thought leaders and developing long-term relationships. For this reason alone, it is important for pharmaceutical companies to build a robust field-based medical team.
And one of the key components of an effective field-based medical team is the allocation of resources, both in terms of staffing and budget levels.
Best Practices, LLC undertook this study to help organizations fill knowledge gaps around key MSL/field-based medical team operational areas, including: staffing levels, resource allocations, revenue supported by MSLs, staffing levels across development phases, and preferred MSL qualification and experience. This research also examines HOL staffing on global field teams.
Research insights will help inform field-based medical and other leadership teams about the region-specific strategies employed by other organizations and help carve out a framework for expanding their footprint in high-potential global markets.
This research provides data in several segments: All Participants (Total Benchmark Class); Global (Outside US); North America Responses; Europe Responses; and JAPAC Responses.
Best Practices, LLC engaged 55 medical affairs and field-based medical team leaders from a total of 36 top pharma and biotech organizations through a benchmarking survey. Six deep-dive interviews were also conducted. To offer clear understanding of field medical trends across major markets, benchmark data is segmented by: Total Benchmark Class (N=69); Global Market Segment, excluding U.S. (N=38); North America Market Segment (N=31); Europe (EU5) Market Segment (N=24); and JAPAC Market Segment (N=5).